These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36868791)

  • 1. Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.
    Chan WKB; Carlson HA; Traynor JR
    Mol Pharmacol; 2023 May; 103(5):274-285. PubMed ID: 36868791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems.
    Ghanakota P; Carlson HA
    J Phys Chem B; 2016 Aug; 120(33):8685-95. PubMed ID: 27258368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor.
    Miao Y; Nichols SE; McCammon JA
    Chem Biol Drug Des; 2014 Feb; 83(2):237-46. PubMed ID: 24112716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).
    MacKerell AD; Jo S; Lakkaraju SK; Lind C; Yu W
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129519. PubMed ID: 31911242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS).
    Feng Z; Liang T; Wang S; Chen M; Hou T; Zhao J; Chen H; Zhou Y; Xie XQ
    ACS Chem Neurosci; 2020 Oct; 11(20):3333-3345. PubMed ID: 32941011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allostery of atypical modulators at oligomeric G protein-coupled receptors.
    Shivnaraine RV; Kelly B; Elmslie G; Huang XP; Dong YJ; Seidenberg M; Wells JW; Ellis J
    Sci Rep; 2021 Apr; 11(1):9265. PubMed ID: 33927236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors.
    Renault P; Giraldo J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators.
    Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.
    Hollingsworth SA; Kelly B; Valant C; Michaelis JA; Mastromihalis O; Thompson G; Venkatakrishnan AJ; Hertig S; Scammells PJ; Sexton PM; Felder CC; Christopoulos A; Dror RO
    Nat Commun; 2019 Jul; 10(1):3289. PubMed ID: 31337749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation in monomers and oligomers of a G protein-coupled receptor.
    Shivnaraine RV; Kelly B; Sankar KS; Redka DS; Han YR; Huang F; Elmslie G; Pinto D; Li Y; Rocheleau JV; Gradinaru CC; Ellis J; Wells JW
    Elife; 2016 May; 5():. PubMed ID: 27151542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation.
    Inan T; Yuce M; MacKerell AD; Kurkcuoglu O
    ACS Omega; 2024 Sep; 9(38):40154-40171. PubMed ID: 39346853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.
    Smith RD; Carlson HA
    J Chem Inf Model; 2021 Mar; 61(3):1287-1299. PubMed ID: 33599485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.
    Dror RO; Green HF; Valant C; Borhani DW; Valcourt JR; Pan AC; Arlow DH; Canals M; Lane JR; Rahmani R; Baell JB; Sexton PM; Christopoulos A; Shaw DE
    Nature; 2013 Nov; 503(7475):295-9. PubMed ID: 24121438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.